TS Financial Group (TSFG)’s CervoMed CRVO Stock Holding History

TS Financial Group (TSFG)’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300	Closed	-$2K	–	829
2025 Q4	$2K	Hold	300	–	–	﹤0.01%	729
2025 Q3	$2K	Buy	+300	New	+$2.57K	﹤0.01%	734

Other funds holding CRVO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TS Financial Group (TSFG)'s CRVO Position: Q1 2026 in Review

TS Financial Group (TSFG) sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 300 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in CRVO in Q3 2025 and held it in 2 quarters. The position peaked at $2K in Q4 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

TS Financial Group (TSFG) reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
TS Financial Group (TSFG) sold 300 CervoMed shares in Q1 2026, an estimated $2K.
TS Financial Group (TSFG) first reported a position in CervoMed in Q3 2025 and held it in 2 quarters.
TS Financial Group (TSFG)'s CervoMed position peaked at $2K in Q4 2025.
36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2026, filed 27 Apr 2026.